FDA Inspection 1006268 — Peter Beitsch, MD

Peter Beitsch, MD — FEI 3013237902

The FDA completed an inspection of Peter Beitsch, MD on Mar 8, 2017 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 8, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.